Getein Biotech Inc (603387) - Total Liabilities

Latest as of March 2026: CN¥765.68 Million CNY ≈ $112.04 Million USD

Based on the latest financial reports, Getein Biotech Inc (603387) has total liabilities worth CN¥765.68 Million CNY (≈ $112.04 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Getein Biotech Inc - Total Liabilities Trend (2012–2025)

This chart illustrates how Getein Biotech Inc's total liabilities have evolved over time, based on quarterly financial data. See Getein Biotech Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Getein Biotech Inc Competitors by Total Liabilities

The table below lists competitors of Getein Biotech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Harbin Jiuzhou Electrical Co Ltd SHE:300040	China	CN¥4.82 Billion
Shenzhen Keanda Electronic Techno SHE:002972	China	CN¥206.27 Million
Beijing Scitop Bio Tech Co Ltd SHE:300858	China	CN¥169.53 Million
Guangdong Eastone Century Technology Co Ltd SHE:300310	China	CN¥1.23 Billion
Korea Investment Holdings Co Ltd KO:071055	Korea	₩124.06 Trillion
CorMedix Inc NASDAQ:CRMD	USA	$420.83 Million
Carriage Services Inc NYSE:CSV	USA	$1.10 Billion
Hunan Fangsheng Pharm Co Ltd SHG:603998	China	CN¥1.22 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Getein Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Getein Biotech Inc.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.21	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.27	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.21	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Getein Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Getein Biotech Inc (2012–2025)

The table below shows the annual total liabilities of Getein Biotech Inc from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥896.55 Million ≈ $131.19 Million	-9.11%
2024-12-31	CN¥986.42 Million ≈ $144.34 Million	-4.27%
2023-12-31	CN¥1.03 Billion ≈ $150.78 Million	+1.73%
2022-12-31	CN¥1.01 Billion ≈ $148.21 Million	+17.24%
2021-12-31	CN¥863.90 Million ≈ $126.42 Million	+24.13%
2020-12-31	CN¥695.95 Million ≈ $101.84 Million	+113.49%
2019-12-31	CN¥325.98 Million ≈ $47.70 Million	+74.11%
2018-12-31	CN¥187.23 Million ≈ $27.40 Million	+57.50%
2017-12-31	CN¥118.87 Million ≈ $17.39 Million	+30.45%
2016-12-31	CN¥91.13 Million ≈ $13.33 Million	+53.21%
2015-12-31	CN¥59.48 Million ≈ $8.70 Million	+44.16%
2014-12-31	CN¥41.26 Million ≈ $6.04 Million	-41.41%
2013-12-31	CN¥70.42 Million ≈ $10.31 Million	+43.27%
2012-12-31	CN¥49.15 Million ≈ $7.19 Million	--

About Getein Biotech Inc

SHG:603387 China Medical Devices

Market Cap

$601.12 Million

CN¥4.11 Billion CNY

Market Cap Rank

#11441 Global

#3279 in China

Share Price

CN¥8.10

Change (1 day)

+1.63%

52-Week Range

CN¥7.78 - CN¥10.65

All Time High

CN¥21.49